Healthcare ECONOMIST

JULY 11, 2024

CONCLUSIONS : Although sotagliflozin adoption reduced health system revenue in an FFS payment model, it led to a net positive financial impact after accounting for APM bonus payments. RESULTS : A typical community hospital would have 83.4 patients per year on average with an index HF hospitalization with comorbid DM.

Pharmaceuticals 70

Pharmaceuticals Accountable Care Accountability Hospitals 70

Healthcare ECONOMIST

NOVEMBER 4, 2024

This is particularly relevant for pharmaceuticals. However, CEAs in the past have rarely accounted for these possibilities and instead assume that a drug’s price remains constant over time. The need for dynamic pricing is particularly important when comparing pharmaceutical to non-pharmaceutical health technologies.

Pharmaceuticals 70

Pharmaceuticals Accountability Health Technology 70

Health Populi

JULY 1, 2020

To the pharmaceutical industry, it’s the annual revenue generated from 323 blockbuster drugs, as “blockbusters” are defined as products yielding $1 bn in sales a year. Hospitals Will Lose $323 Billion in 2020 – Before Accounting for Growing COVID Cases appeared first on HealthPopuli.com. The post U.S.

Accountability 127

Accountability Hospitals Doctors Pharmaceuticals 127

HIT Consultant

DECEMBER 7, 2023

Lance Hill, CEO of Within3 The cancer market for the pharma industry accounts for about a third of their product pipeline. In this nuanced landscape, pharmaceutical companies play a vital role in driving advancements in cancer care. A recent study estimated the cost of developing a new drug at $2.6

Life Sciences 98

Life Sciences Pharmaceuticals Accountability Healthcare Improvement 98

Healthcare ECONOMIST

JULY 3, 2024

Created in 1992, the program requires pharmaceutical manufacturers to sell outpatient drugs at significantly discounted prices (typically 25% to 50% off) to eligible hospitals, clinics, and health centers that care for a large number of uninsured and low-income patients. Why would 340B increase cost?

Medicaid 114

Medicaid Pharmaceuticals Hospitals Accountability 114

Healthcare It News

JANUARY 18, 2022

Care managers and social workers, working within accountable care organizations, and physician provider networks now incorporate a short series of SDOH interview questions with patients identified as high-risk for poor healthcare outcomes or unnecessary future healthcare expenditures.

Pharmaceuticals 353

Pharmaceuticals Accountable Care Accountability Medicaid 353

Bill Of Health

OCTOBER 28, 2022

The selections feature topics ranging from an examination of Park doctrine prosecutions of executives of pharmaceutical and medical device companies, an analysis of patent thickets covering biologic drugs, and a discussion of product hopping strategies among manufacturers of inhalers. The Political Economy of Market Power in Pharmaceuticals.

Pharmaceuticals 96

Pharmaceuticals Regulations Accountability Medicaid 96

Healthcare ECONOMIST

DECEMBER 17, 2023

The share of the economy accounted for by the health sector was 17.3 Pharmaceutical spending as a share of total health care spending has been relatively constant at around 9% throughout the past 7 years. The insured share of the population reached a historic high of 92.0 percent in 2022, which was down from a peak of 19.5

Pharmaceuticals 102

Pharmaceuticals Medicaid Accountability 102

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

Healthcare ECONOMIST

AUGUST 1, 2022

For large publicly traded pharmaceutical firms, research and other costs are public on their financial statements. It may appear on financial statements that successful pharmaceutical make outsized profits, but these figures must also take into account that many pharmaceutical firms have drugs that fail and the companies go out of business.

Pharmaceuticals 72

Pharmaceuticals Biotechnology Accountability 72

Healthcare ECONOMIST

MARCH 22, 2022

Based on analysis from National Income and Product Accounts (NIPAs), multifactor productivity (MFP) in the health care and social assistance sector declined by 0.4% Another issue is that in national accounts, each provider type (e.g., hospitals, physicians, pharmaceuticals) is treated as a separate industry. increase in MFP.

Pharmaceuticals 71

Pharmaceuticals Accountability Medicare Hospitals 71

Bill Of Health

OCTOBER 26, 2023

However, the deep wounds of the pandemic remain, compelling those concerned about this pandemic and future health emergencies to account for catastrophic failures by those in power. That has created deep inequities in access to health products that can save lives.

Accountability 121

Accountability Prevention Pharmaceuticals Regulations 121

Bill Of Health

DECEMBER 27, 2021

Engaging parameters,” accountability and benefit , redirect attention from those who experience injustice to those who contribute to or enjoy from the status quo. While the engagement of the UN , WHO , or governments is obvious, the accountability parameter may also engage other stakeholders to sit at the table.

Accountability 105

Accountability Pharmaceuticals Regulations Prevention 105

HIT Consultant

NOVEMBER 20, 2024

– Peter Doumas, Chief Revenue Officer: Former Vice President of National Key Accounts at Progyny and Anthem. Kumar Dharmarajan, Chief Medical Officer: Former Chief Scientific Officer at Clover Health and a professor at Yale University.

Doctors 97

Doctors Pharmaceuticals Nursing Medicare 97

HIT Consultant

SEPTEMBER 26, 2022

The new normal has thrown up opportunities as well as risks for pharmaceutical companies. Nevertheless, there is a downward trend in the consumption of prescription medicine due to lower spending, apart from increased competition from generics and rising instances of pharmaceutical fraud and counterfeiting that lead to consumer distrust (2).

Life Sciences 97

Life Sciences Pharmaceuticals Telemedicine Healthcare Providers 97

NCQA

NOVEMBER 8, 2024

Despite decades of advances in respiratory care that can help make the condition manageable, patients with asthma accounted for nearly 1 million emergency department visits in 2020, and approximately 95,000 inpatient hospital stays. Asthma is a complex, chronic disease that affects approximately 24 million people in the U.S.

Pharmaceuticals 52

Pharmaceuticals Clinical Practice Primary Care Accountability 52

Sheppard Health Law

JUNE 21, 2023

This month, pharmaceutical manufacturer, Merck & Co., First Amendment Allegation: The Complainants allege that the excise tax effectively coerces pharmaceutical manufacturers into agreeing to a maximum price that they must endorse, against their will, as “fair” pursuant to the negotiations. What does this mean for the industry?

Pharmaceuticals 52

Pharmaceuticals Medicare Accountability 52

Healthcare ECONOMIST

OCTOBER 19, 2023

However, CEAs in the past have rarely accounted for these possibilities and instead assume that a drug’s price remains constant over time. A static drug pricing assumption fails to account for anticipated savings from the genericization of the alternative treatment.

Pharmaceuticals 75

Pharmaceuticals Accountability 75

HIT Consultant

APRIL 15, 2024

In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. They are also in communication with the sponsor, who is the MAH of the active pharmaceutical ingredient. In comparison to Japan, China has fewer distinctions.

Pharmaceuticals 96

Pharmaceuticals Patient Safety Accountability Integration 96

Bill Of Health

DECEMBER 12, 2023

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.

Pharmaceuticals 59

Pharmaceuticals Accountability Regulations Prevention 59

Health Business Group

JUNE 13, 2024

Despite an initial interest in accounting, Jordan's passion for pharma led him down a path less traveled, avoiding the conventional business routes of consulting and investment banking. Next, we take a closer look at Jordan's dynamic career in the pharmaceutical industry.

Pharmaceuticals 52

Pharmaceuticals Accountability Healthcare 52

Healthcare ECONOMIST

JUNE 13, 2022

Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. Clinical trial costs account for 94% of the total investment, with manufacturing costs accounting for only 6%. A study by Ahuja et al. trillion in social value. per annum and a net present value of –$9.5

Life Sciences 89

Life Sciences Pharmaceuticals Accountability Prevention 89

HIT Consultant

AUGUST 16, 2023

This technology enables pharmaceutical and biotech customers to consider decentralized and hybrid clinical trial strategies in study protocols that would have otherwise been limited to on-site evaluations.

Pharmaceuticals 52

Pharmaceuticals Accountability Integration Life Sciences 52

Bill Of Health

DECEMBER 22, 2023

Pharmaceutical companies should consider adopting an “access by design” approach, i.e., embedding fairer and equitable access to intellectual property at all stages of drug development and deployment. One way forward that was discussed was a collaborative and voluntary mechanism.

Pharmaceuticals 64

Pharmaceuticals Accountability Doctors Hospitals 64

Sheppard Health Law

JULY 10, 2023

On June, 23, 2023, New York City Mayor Eric Adams signed the Healthcare Accountability and Consumer Protection Act ( Intro. This local law amends the New York City Charter and directs the Mayor to establish an Office of Healthcare Accountability – the first of its kind in the country.

Accountability 52

Accountability Pharmaceuticals Hospitals Medicaid 52

Healthcare ECONOMIST

MAY 31, 2022

Even if IRP was implemented however, IRP programs differ across a number dimensions including: Number/type of countries referenced Method of calculating prices (eg, minimum, median, mean, or a weighted index of referenced countries); How the prices are obtained (eg, from pharmaceutical manufacturer or external sources); Type of price used (e.g.,

Pharmaceuticals 74

Pharmaceuticals Accountability 74

HIT Consultant

NOVEMBER 25, 2024

Starting with clinical trial site selection, the age-old process of designing and planning a clinical trial—which, in most cases, has not evolved for the last two decades —involves a pharmaceutical sponsor working with a contract research organization (CRO) to identify several clinical sites from their clinician networks.

Life Sciences 98

Life Sciences Pharmaceuticals Integration Regulations 98

Bill Of Health

OCTOBER 29, 2021

The Doha Declaration , enacted in 2001, attempts to address global inequities stemming from intellectual property protections by allowing countries to grant compulsory licenses for the production of pharmaceuticals for international exports. Accountability mechanisms are also imperative to ensure the facility’s effective functioning.

Pharmaceuticals 144

Pharmaceuticals Accountability Prevention Biotechnology 144

HIT Consultant

JANUARY 30, 2024

Price of Specialty Medications The majority of the top 15 medications in spend among Vizient pharmacy program participants fall under specialty pharmaceuticals, addressing high-cost, complex, or chronic conditions such as cancer, infectious diseases, autoimmune disorders, and pulmonary conditions.

Pharmaceuticals 98

Pharmaceuticals Performance improvement Accountability Prevention 98

Healthcare ECONOMIST

FEBRUARY 19, 2024

Casgevy” from Vertex Pharmaceuticals and CRISPR Therapeutics had a list price of $2.2 Note that the patient outcome rebates can be paid annually over time to account for cases where patients respond to therapy but perhaps not indefinitely. Two CGTs for the treatment of sickle cell disease are planned for inclusion in the model.

Medicaid 115

Medicaid Pharmaceuticals Accountability 115

HIT Consultant

OCTOBER 20, 2023

According to a study in the Journal of the American Geriatric Society , non-fatal falls cost an estimated $50 billion in medical expenses, while fatal falls account for an estimated $754 million. Prior to Dominion, Dr. Fornari was a research scientist and consultant to the pharmaceutical industry. It is also an expensive problem.

Rehabilitation 105

Rehabilitation Pharmaceuticals Prevention Biotechnology 105

Healthcare ECONOMIST

APRIL 2, 2024

One key question is what factors do US payers take into account when evaluating DTx and how does that differ from standard pharmaceuticals. A paper by Gomez Lumbreras et al. 2024) held virtual focus groups with 21 US payers to find the answer. Key considerations include: Need for Evidence.

Pharmaceuticals 73

Pharmaceuticals Regulations Accountability Prevention 73

HIT Consultant

MAY 2, 2022

The pharmaceutical industry differs in many ways from other industries. Along this entire path, the organization must ensure that diverse voices are included and the needs of diverse patient populations are taken into account. Diversity needs to become part of the fabric of pharmaceutical companies and the industry as a whole.

Life Sciences 98

Life Sciences Pharmaceuticals Healthcare Providers Healthcare 98

HIT Consultant

AUGUST 5, 2022

Supply costs are often less significant in the cost structure of PPM companies, and campaigns run by large drug companies in an effort to increase market share for pharmaceuticals coming off patent expiration may generate additional opportunities for PPM companies to achieve higher margins on J-Code drug billing.

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

HIT Consultant

JUNE 18, 2024

What You Should Know: – Mika Health , a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo. million new cases were diagnosed, accounting for one in four new cancer cases.

Pharmaceuticals 52

Pharmaceuticals Regulations Accountability Life Sciences 52

Healthcare ECONOMIST

AUGUST 8, 2022

The national Dental and Pharmaceutical Benefits Agency (TLV), regulates which drugs are included in the national pharmaceutical benefits scheme based on health need, disease severity, and cost-effectiveness…If a drug is approved, it is sold at private pharmacies throughout the country at the fixed price agreed by the producer and TLV.

Pharmaceuticals 67

Pharmaceuticals Regulations Accountability Medicare 67

Healthcare ECONOMIST

MAY 18, 2022

As summarized an ISPOR’s Value and Outcomes Spotlight article titled “ Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration? What considerations beyond quality adjusted life years and cost should be considered when evaluating gene therapies? A panel from ISPOR provided just such a discussion.

Pharmaceuticals 70

Pharmaceuticals Accountability 70